@NextechInvest

Finding and fueling tomorrow’s advances in precision medicine.

 Zurich, Switzerland
nextechinvest.com
Joined April 2017
  • Tweets289
  • Following101
  • Followers328
19Media
Today, we announced a $100 million private placement. This financing, together with Context's existing cash and cash equivalents, is expected to extend our cash runway into 2028. $CNTX ir.contexttherapeutics.com/n…
2
14
2,286
$RVMD and $EQRX merge to build a Ras powerhouse. globenewswire.com/news-relea…

Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1...

Revolution Medicines Expects to Conduct Late-Stage Development of RAS(ON) Inhibitor Drug Candidate Pipeline Supported by Fortified Balance Sheet Agreement...

globenewswire.com
1
1
2
3,273
prnewswire.com/news-releases…

K36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of...

/PRNewswire/ -- K36 Therapeutics ("K36"), a privately held clinical-stage biotech company developing KTX-1001, an investigational small molecule...

prnewswire.com
1
3
554
Congrats @oricpharma and @JacobChackoMD on closing this PIPE. It also marks @NextechInvest first PIPE investment. We are excited about working together with this very talented team to advance the high potential pipeline globenewswire.com/news-relea…

ORIC Pharmaceuticals Announces $85 Million Private Placement Financing

Financing led by Nextech and includes participation from EcoR1 Capital, Frazier Life Sciences, Venrock Healthcare Capital Partners, and Boxer Capital Pro...

globenewswire.com
1
1
3
2,232
Congratulations to Fred Hutch's Dr. Phil Greenberg on his election to @theNASciences! Greenberg is an internationally-recognized expert in cancer #immunotherapy, a form of therapy that aims to harness the power of immune cells to eliminate #cancer. bit.ly/3AQpjwj
1
4
2
65
9,366
Thank you @Nasdaq for highlighting our recent financing of Alpha-9. Great team, science and syndicate!
1
2
600
"I think success is having a career where you enjoy it so much that you almost feel guilty that people pay you to do it because you are having so much fun every day." Wise words by our 2019 medicine laureate William Kaelin. #NobelPrize

William Kaelin on success

11
225
24
754
Farewell to our latest graduate, Dr. @StellaPaff, and best of luck for her next endeavor @NextechInvest! #LoweLab25 – at Manhattan, NY
1
1
46
So grateful for the incredible LPs who joined our healthcare SIG this afternoon and shared how venture firms can create value, promote ongoing engagement, and prioritize LP's unique motivations. Shout out to our moderator, Melisa McCracken of @NextechInvest 👋🏽🔥
1
1
3
Nextech retweeted
STAT
@statnews2 Aug 2022
IDRx is starting off with $122 million and two licensed drug candidates it plans to combine to create a treatment for gastrointestinal stromal tumors, or GIST. buff.ly/3zqDHu3
3
4
Startup IDRx raises $122m to focus on combination drug treatments trib.al/u6x54bm
3
2
1
IDRx is launching w/ $122m to treat cancer with ‘purpose-built’ precision combination therapies. @a16z is thrilled to co-lead this financing w/ @cascapital + participation from @NextechInvest, Forge Life Science Partners & other investors. idrx.com/press-releases/idrx…
1
3
6
At Arrakis, we have a simple but powerful vision: To extend medicines into new realms of biology by discovering and developing rSMs (RNA-targeted small molecules) that act directly on RNA to treat disease. Happy #RNADay!
1
10
We are thrilled to announce our collaboration with Merck to evaluate PC14586 in combination with Merck’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) in patients with advanced solid tumors. globenewswire.com/news-relea… #p53 #oncology

PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in...

Combination trial to be initiated in Q4 2022...

globenewswire.com
2
2
Please join us in congratulating our Co-Founder, Luc Brunsveld, on his election to the Royal Dutch Academy of Sciences. Beyond his work as a professor at @TUeindhoven, Luc’s leadership and scientific contributions to the Ambagon team are appreciated and celebrated every day.
This Post is from an account that no longer exists. Learn more
1
1
4
This week our CSO, @NanPry, is at the second Annual Induced Proximity-Based Drug Discovery Summit in Boston to share the latest on Ambagon’s work developing a modular approach to drug discovery. Nancy will speak on Thursday, May 12. More on this event: bit.ly/3k3j28k
2
2
We're excited to announce the completion of our Series B financing, advancing our novel #drugdiscovery platform to develop precision medicines for patients in need. Read more here: businesswire.com/news/home/2…
1
5
4
9
Fueling the motors! Great sign of life in this market. Strong science will always get funded. We believe in #biotech. We'll done @moma_tx and great to work with a strong syndicate of @ThirdRockV, Cormorant, @section32vc, @NextechInvest and the new lead @GoldmanSachs
Christoph Lengauer@c_lengauer10 May 2022
Working like a machine endpts.com/working-like-a-ma…

Working like a machine during the pandemic, MOMA taps investors to bankroll its 'molecular machines'

For a biotech that opened its lab the week before the pandemic shuttered many offices, MOMA Therapeutics has experienced hardly a blip in operations, so much so that it attracted ...

endpoints.news
1
2
Today we announced clinical data from our ongoing Phase 1/2 clinical trial of CFT7455 for the treatment of multiple myeloma and non-Hodgkin’s lymphomas, to be presented at #AACR22. Read more in our news release: bit.ly/3r8j2aQ
1
3
3
Load more